{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:02:03Z","timestamp":1784764923031,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-026-27946-5","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T03:14:47Z","timestamp":1779851687000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Acceptability and implementation considerations for community pharmacy\u2013based delivery of pre-exposure prophylaxis and antiretroviral therapy in Dar es Salaam: a sequential explanatory mixed-methods design"],"prefix":"10.1186","volume":"26","author":[{"given":"George Msema","family":"Bwire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabel","family":"Itaeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Japhet","family":"Killewo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Sudfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"27946_CR1","unstructured":"Global HIV. & AIDS statistics \u2014 Fact sheet, UNAIDS, 2024. Accessed: Nov. 21, 2025. [Online]. Available: https:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"key":"27946_CR2","unstructured":"Sundareshan V, Swinkels HM, Nguyen AD, Mangat R, Koirala J. Preexposure Prophylaxis for HIV Prevention. 2025."},{"key":"27946_CR3","unstructured":"WHO. Guidelines for HIV post-exposure prophylaxis, 2024. Accessed: Dec. 31, 2025. [Online]. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240095137."},{"key":"27946_CR4","doi-asserted-by":"publisher","unstructured":"Dwyer-Lindgren L et al. Jun., Mapping HIV prevalence in sub-Saharan Africa between 2000 and 2017, Nature, vol. 570, no. 7760, p. 189\u2013193, 2019, https:\/\/doi.org\/10.1038\/s41586-019-1200-9.","DOI":"10.1038\/s41586-019-1200-9"},{"key":"27946_CR5","unstructured":"National Bureau of Statistics. Tanzania HIV Impact Survey 2022\u20132023. Accessed: Feb. 01, 2024. [Online]. Available: https:\/\/www.nbs.go.tz\/index.php\/en\/census-surveys\/health-statistics\/hiv-and-malaria-survey\/932-the-tanzania-hiv-impact-survey-2022-2023-summary-sheet."},{"key":"27946_CR6","unstructured":"UNAIDS. HIV and AIDS Estimates Country factsheets United Republic of Tanzania. Accessed: Apr. 16, 2023. [Online]. Available: https:\/\/www.unaids.org\/en\/regionscountries\/countries\/unitedrepublicoftanzania."},{"key":"27946_CR7","doi-asserted-by":"publisher","unstructured":"Iseselo MK, Ambikile JS, Lukumay GG, Mosha IH. Challenges in the delivery of health services for people living with HIV in Dar es Salaam, Tanzania: a qualitative descriptive study among healthcare providers, Frontiers in Health Services, vol. 4, Feb. 2024, https:\/\/doi.org\/10.3389\/frhs.2024.1336809.","DOI":"10.3389\/frhs.2024.1336809"},{"key":"27946_CR8","unstructured":"National AIDS Control Programme. The United Republic of Tanzania, HIV Treatment Guideline, 2019. Accessed: Mar. 03, 2023. [Online]. Available: https:\/\/differentiatedservicedelivery.org\/wp-content\/uploads\/national_guidelines_for_the_management_of_hiv_and_aids_2019.pdf."},{"key":"27946_CR9","unstructured":"Consolidated guidelines on HIV. viral hepatitis and STI prevention, diagnosis, treatment and care for key populations, Accessed: May 09, 2024. [Online]. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240052390."},{"key":"27946_CR10","doi-asserted-by":"publisher","unstructured":"Avong YK, et al. Integrating community pharmacy into community based anti-retroviral therapy program: A pilot implementation in Abuja, Nigeria. PLoS ONE. Jan. 2018;13(1). https:\/\/doi.org\/10.1371\/journal.pone.0190286.","DOI":"10.1371\/journal.pone.0190286"},{"key":"27946_CR11","doi-asserted-by":"publisher","unstructured":"Mugo PM, et al. Uptake and acceptability of oral HIV self-testing among community pharmacy clients in Kenya: A feasibility study. PLoS ONE. Jan. 2017;12(1). https:\/\/doi.org\/10.1371\/journal.pone.0170868.","DOI":"10.1371\/journal.pone.0170868"},{"key":"27946_CR12","doi-asserted-by":"publisher","unstructured":"Asieba IO, et al. Antiretroviral therapy in community pharmacies - Implementation and outcomes of a differentiated drug delivery model in Nigeria. Res Social Administrative Pharm. 2021;17(5):842\u20139. https:\/\/doi.org\/10.1016\/j.sapharm.2020.06.025.","DOI":"10.1016\/j.sapharm.2020.06.025"},{"key":"27946_CR13","doi-asserted-by":"publisher","unstructured":"Bwire GM et al. Impact of differentiated service delivery models on retention in HIV care and viral suppression among people living with HIV in sub-Saharan Africa: A systematic review and meta-analysis of randomised controlled trials, Nov. 01, 2023, John Wiley and Sons Ltd. https:\/\/doi.org\/10.1002\/rmv.2479.","DOI":"10.1002\/rmv.2479"},{"key":"27946_CR14","doi-asserted-by":"publisher","unstructured":"Harrison C, et al. Facilitators and barriers to community pharmacy PrEP delivery: a scoping review. J Int AIDS Soc. Mar. 2024;27(3). https:\/\/doi.org\/10.1002\/jia2.26232.","DOI":"10.1002\/jia2.26232"},{"key":"27946_CR15","unstructured":"Decentralized Drug Distribution (DDD) Learning Collaborative. Community pharmacy ART distribution models, 2020, Accessed: Jun. 26, 2025. [Online]. Available: chrome-extension:\/\/efaidnbmnnnibpcajpcglclefindmkaj\/https:\/\/www.differentiatedservicedelivery.org\/wp-content\/uploads\/community_pharmacy_art_distribution_models_7.30.20.pdf"},{"key":"27946_CR16","unstructured":"Bringing ART. Closer to Communities: The Role of Community Pharmacy DSD Models. Accessed: Feb. 23, 2026. [Online]. Available: https:\/\/cquin.icap.columbia.edu\/wp-content\/uploads\/2022\/08\/Community-Pharmacy_MASTER.pdf."},{"key":"27946_CR17","unstructured":"United Republic of Tanzania(URT). Pharmacy Council - Tanzania. Accessed: Jan. 28, 2024. [Online]. Available: https:\/\/www.pc.go.tz\/"},{"key":"27946_CR18","doi-asserted-by":"publisher","unstructured":"Kennedy CE, Yeh PT, Atkins K, Ferguson L, Baggaley R, Narasimhan M. PrEP distribution in pharmacies: a systematic review. BMJ Open. 2022;12(2):e054121. https:\/\/doi.org\/10.1136\/bmjopen-2021-054121.","DOI":"10.1136\/bmjopen-2021-054121"},{"key":"27946_CR19","unstructured":"National Bureau of Statistics. Tanzania Population and Housing Census 2022, Accessed: Mar. 22, 2025. [Online]. Available: https:\/\/www.nbs.go.tz\/uploads\/statistics\/documents\/sw-1720088450-2022%20PHC%20Initial%20Results%20-%20English.pdf."},{"key":"27946_CR20","doi-asserted-by":"publisher","unstructured":"Mizinduko M et al. Sep., HIV prevalence and associated risk factors among female sex workers in Dar es Salaam, Tanzania: tracking the epidemic. Int J STD AIDS. 2020;31(10):950\u2013957. https:\/\/doi.org\/10.1177\/0956462420917848.","DOI":"10.1177\/0956462420917848"},{"key":"27946_CR21","doi-asserted-by":"publisher","unstructured":"Vu L, Misra K. High Burden of HIV, Syphilis and HSV-2 and Factors Associated with HIV Infection Among Female Sex Workers in Tanzania: Implications for Early Treatment of HIV and Pre-exposure Prophylaxis (PrEP). AIDS Behav. 2018;22(4):1113\u20131121. https:\/\/doi.org\/10.1007\/s10461-017-1992-2.","DOI":"10.1007\/s10461-017-1992-2"},{"key":"27946_CR22","doi-asserted-by":"publisher","unstructured":"Arya R, Antonisamy B, Kumar S. Sample size estimation in prevalence studies. Indian J Pediatr. 2012;79(11):1482\u20138. https:\/\/doi.org\/10.1007\/s12098-012-0763-3.","DOI":"10.1007\/s12098-012-0763-3"},{"key":"27946_CR23","doi-asserted-by":"publisher","unstructured":"Sekhon M, Cartwright M, Francis JJ. Development of a theory-informed questionnaire to assess the acceptability of healthcare interventions. BMC Health Serv Res. 2022;22(1). https:\/\/doi.org\/10.1186\/s12913-022-07577-3.","DOI":"10.1186\/s12913-022-07577-3"},{"key":"27946_CR24","doi-asserted-by":"publisher","unstructured":"Weiner BJ, et al. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017;12(1). https:\/\/doi.org\/10.1186\/s13012-017-0635-3.","DOI":"10.1186\/s13012-017-0635-3"},{"key":"27946_CR25","doi-asserted-by":"publisher","unstructured":"Chandra C, Hudson AF, Alohan DI, Young HN, Crawford ND. Implementation Science of Integrating Pre-Exposure Prophylaxis in Pharmacist-Led Services in the United States. Curr. HIV\/AIDS Rep. 2024;21(4):197\u2013207. https:\/\/doi.org\/10.1007\/s11904-024-00700-5","DOI":"10.1007\/s11904-024-00700-5"},{"key":"27946_CR26","doi-asserted-by":"publisher","unstructured":"Koo M, Yang S-W, Scale L-T. Encyclopedia. Feb. 2025;5(1):18. https:\/\/doi.org\/10.3390\/encyclopedia5010018.","DOI":"10.3390\/encyclopedia5010018"},{"key":"27946_CR27","doi-asserted-by":"publisher","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u2013357. https:\/\/doi.org\/10.1093\/intqhc\/mzm042","DOI":"10.1093\/intqhc\/mzm042"},{"key":"27946_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/160940690600500107","volume":"5","author":"J Fereday","year":"2006","unstructured":"Fereday J, Muir-Cochrane E, Fereday Rgn J, Dip G, Ed A. Demonstrating Rigor Using Thematic Analysis: A Hybrid Approach of Inductive and Deductive Coding and Theme Development. Int J Qual Methods. 2006;5:51.","journal-title":"Int J Qual Methods"},{"key":"27946_CR29","doi-asserted-by":"publisher","unstructured":"Damschroder LJ, Reardon CM, Widerquist MAO, Lowery J. The updated Consolidated Framework for Implementation Research based on user feedback. Implement Sci. 2022;17(1):75. https:\/\/doi.org\/10.1186\/s13012-022-01245-0.","DOI":"10.1186\/s13012-022-01245-0"},{"issue":"2","key":"27946_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/02607476.2013.866724","volume":"40","author":"A Edwards-Jones","year":"2014","unstructured":"Edwards-Jones A. Qualitative data analysis with NVIVO. J Educ Teach. 2014;40(2):193\u20135. https:\/\/doi.org\/10.1080\/02607476.2013.866724.","journal-title":"J Educ Teach"},{"key":"27946_CR31","doi-asserted-by":"publisher","unstructured":"Turner SF, Cardinal LB, Burton RM. Research Design for Mixed Methods: A Triangulation-based Framework and Roadmap. Organ Res Methods. 2017;20(2):243\u201367. https:\/\/doi.org\/10.1177\/1094428115610808.","DOI":"10.1177\/1094428115610808"},{"key":"27946_CR32","doi-asserted-by":"publisher","unstructured":"The Role of Stigma in HIV Prevention. A Focused Analysis of PrEP Hesitancy in Guyana. Texila Int J Public Health. 2025;13(4). https:\/\/doi.org\/10.21522\/TIJPH.2013.13.04.Art018.","DOI":"10.21522\/TIJPH.2013.13.04.Art018"},{"key":"27946_CR33","doi-asserted-by":"publisher","unstructured":"Bacci JL et al. Community pharmacist patient care services: A systematic review of approaches used for implementation and evaluation. JACCP. 2019;2(4):423\u2013432. https:\/\/doi.org\/10.1002\/jac5.1136.","DOI":"10.1002\/jac5.1136"},{"key":"27946_CR34","doi-asserted-by":"publisher","unstructured":"Tembo A, et al. Leveraging community pharmacies for HIV services in South Africa: Opportunities and constraints. South Afr J HIV Med. 2025. https:\/\/doi.org\/10.4102\/SAJHIVMED.v26i1.1739.","DOI":"10.4102\/SAJHIVMED.v26i1.1739"},{"key":"27946_CR35","doi-asserted-by":"publisher","unstructured":"Nyamuzihwa T, Oladimeji KE, Nyatela A, Makola L, Lalla-Edward ST, Tembo A. Setting up a pharmacy HIV pre-exposure prophylaxis delivery model: Lessons and recommendations for implementation. South Afr J HIV Med. 2025;26:1. https:\/\/doi.org\/10.4102\/sajhivmed.v26i1.1683.","DOI":"10.4102\/sajhivmed.v26i1.1683"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-27946-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27946-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27946-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:17:45Z","timestamp":1784762265000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-27946-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["27946"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-27946-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9530938\/v1","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"26 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study was obtained from the Muhimbili University of Health and Allied Sciences Research Ethics Committee (Ref No. MUHAS-REC-07-2025-3022) and the National Institute for Medical Research through the Dar es Salaam Urban Cohort Study platform (Ref No. NIMR\/HQ\/Vol.1\/3047). Administrative permission to collect data in Dar es Salaam and access the HIV clinics was obtained from the Prime Minister\u2019s Office\u2013Regional Administration and Local Government and the Dar es Salaam Regional Administrative Secretariat. All participants provided written informed consent prior to enrollment. The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"2205"}}